1. EP-1374 ECOG-PS and its changes in inoperable stage III NSCLC patients treated with chemoradiotherapy. (April 2019) Authors: Käsmann, L.; Taugner, J.; Eze, C.; Dantes, M.; Roengvoraphoj, O.; Gennen, K.; Karin, M.; Tufman, A.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1375 Heterogeneity score in inoperable stage III NSCLC patients treated with definitive chemoradiotherapy. (April 2019) Authors: Taugner, J.; Käsmann, L.; Eze, C.; Dantes, M.; Roengvoraphoj, O.; Gennen, K.; Karin, M.; Tufman, A.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Identification of a plasma miRNA biomarker signature for allergic asthma: A translational approach. Issue 12 (19th June 2017) Authors: Milger, K.; Götschke, J.; Krause, L.; Nathan, P.; Alessandrini, F.; Tufman, A.; Fischer, R.; Bartel, S.; Theis, F. J.; Behr, J.; Dehmel, S.; Mueller, N. S.; Kneidinger, N.; Krauss‐Etschmann, S. Journal: Allergy Issue: Volume 72:Issue 12(2017:Dec.) Page Start: 1962 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-0780 Prognostic value of PD-L1 expression in locally advanced NSCLC treated with chemoradiotherapy. (April 2019) Authors: Gennen, K.; Käsmann, L.; Eze, C.; Dantes, M.; Roengvoraphoj, O.; Taugner, J.; Neumann, J.; Mille, E.; Tufman, A.; Huber, R.M.; Orth, M.; Reu, S.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-0999: Deciphering the tumor microenviroment based on PD-L1 expression and CD8 + TILs density in LA-NSCLC. (November 2020) Authors: Käsmann, L.; Gennen, K.; Taugner, J.; Eze, C.; Karin, M.; Roengvoraphoj, O.; Neumann, J.; Tufman, A.; Orth, M.; Reu, S.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-1029: Preliminary analysis of patient cohorts treated pre vs post approval of consolidation IO in LANSCLC. (November 2020) Authors: Taugner, J.; Käsmann, L.; Eze, C.; Roengvoraphoj, O.; Tufman, A.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-1166 Treatment patterns and efficacy of durvalumab maintenance after CRT in real-world NSCLC patients. (August 2021) Authors: Taugner, J.; Käsmann, L.; Eze, C.; Flörsch, B.; Guggenberger, J.; Tufman, A.; Reinmuth, N.; Duell, T.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S968 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PO-1195 Residual MTV after chemoradiotherapy ± immune checkpoint inhibition for inoperable stage III NSCLC. (August 2021) Authors: Taugner, J.; Unterrainer, M.; Käsmann, L.; Eze, C.; Kunz, W.; Tufman, A.; Reinmuth, N.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PO-1252 Treatment patterns and prognosis in inoperable stage III NSCLC treated with concurrent CRT +/- ICI. (May 2022) Authors: Flörsch, B.; Taugner, J.; Käsmann, L.; Kenndoff, S.; Guggenberger, J.; Tufman, A.; Reinmuth, N.; Duell, T.; Belka, C.; Eze, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1056 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prevalence and risk factors of brain metastases in patients with newly diagnosed advanced non-small-cell lung cancer. (2015) Authors: Duell, T.; Kappler, S.; Knöferl, B.; Schuster, T.; Hochhaus, J.; Morresi-Hauf, A.; Huber, RM.; Tufman, A.; Zietemann, V. Journal: Cancer treatment communications Issue: Volume 4(2016)Supplement 1 Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗